Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Guangnan Li"'
Autor:
Guangnan Li, Zhidong Tang, Weiliang Fan, Xi Wang, Li Huang, Yu Jia, Manli Wang, Zhihong Hu, Yu Zhou
Publikováno v:
Cell Insight, Vol 2, Iss 1, Pp 100068- (2023)
The proteins and RNAs of viruses extensively interact with host proteins after infection. We collected and reanalyzed all available datasets of protein-protein and RNA-protein interactions related to SARS-CoV-2. We investigated the reproducibility of
Externí odkaz:
https://doaj.org/article/81a8ccd9e05d46e5a42e0c5987b598b5
Autor:
Dehui Liu, Shangrong Zou, Guangnan Li, Qiyu Zhang, Chunlin Chen, Cuizhi Li, Huafeng Song, Shaoxian Chen, Jiawen Wang, Yueheng Wu, Youbin Liu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
Acute myocardial infarction (MI) is one of the leading causes of death in the world, and its pathophysiological mechanisms have not been fully elucidated. The purpose of this study was to investigate the role and mechanism of uncoupling protein 2 (UC
Externí odkaz:
https://doaj.org/article/986790e5b28949d89b341ed70132f77d
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 6, Pp 2182-2193 (2017)
Background/Aims: Cardiotoxicity is a predominant side-effect of nilotinib during chronic myeloid leukemia treatment. The underlying molecular mechanism remains unclear. The role of autophagy and mitochondrial signaling was investigated in nilotinib-t
Externí odkaz:
https://doaj.org/article/92d7e2c9a96b461f853d182fd50673ed
Autor:
Youbin Liu, Daliang Zhou, Guangnan Li, Xing Ming, Ying feng Tu, Jinwei Tian, Huimin Lu, Bo Yu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 35, Iss 5, Pp 1986-1998 (2015)
Background/Aims: Urothelial carcinoma-associated 1 (UCA1) is a recently identified long non coding RNA (lncRNA). However, few studies have explored its role in cardiomyocytes after focal cardiac ischemia reperfusion injury (CIR). Methods: Rat CIR mod
Externí odkaz:
https://doaj.org/article/f2f4dd9fe4514f989a219f964bb00942
Autor:
Yuhua Fan, Li Liu, Kun Fang, Tao Huang, Lin Wan, Youbin Liu, Sen Zhang, Dongxia Yan, Guangnan Li, Yanhui Gao, Yanjie Lv, Yanjun Chen, Yingfeng Tu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 4 (2016)
BackgroundThe polyphenol resveratrol (Rev) has been reported to exhibit cardioprotective effects, such as inhibition of TAC (transverse aortic constriction) or isoprenaline (ISO)‐induced hypertrophy. MicroRNA‐155 (miR‐155) was found to be decre
Externí odkaz:
https://doaj.org/article/e10ebc95692a408c98d0e30d2a291c2e
Autor:
Tianli He, Zhiran Jin, Wei Hu, Xiaoxue Xia, Donghui Li, Weiyun Yao, Guangnan Li, Xuefeng Zhou, Guoqiang Song
Publikováno v:
Antonie van Leeuwenhoek. 116:565-576
Cryptococcal species often cause lung infections and are the main cause of fungal meningitis. Claudin-4 appears to be a major structural component that maintains a tight alveolar barrier and prevents fluid and electrolyte leakage into the alveolar sp
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 48:1137-1149
Circular RNAs (circRNAs) are widely expressed in mammals and act as regulatory targets in the atherogenesis. The objective of this study was to research the biological role and molecular mechanism of circ_0093887 in oxidized low-density lipoprotein (
Autor:
Bingbing Xu, Yanda Zhu, Changchang Cao, Hao Chen, Qiongli Jin, Guangnan Li, Junfeng Ma, Siwy Ling Yang, Jieyu Zhao, Jianghui Zhu, Yiliang Ding, Xianyang Fang, Yongfeng Jin, Chun Kit Kwok, Aiming Ren, Yue Wan, Zhiye Wang, Yuanchao Xue, Huakun Zhang, Qiangfeng Cliff Zhang, Yu Zhou
Publikováno v:
Science China Life Sciences
RNA structures are essential to support RNA functions and regulation in various biological processes. Recently, a range of novel technologies have been developed to decode genome-wide RNA structures and novel modes of functionality across a wide rang
Autor:
Guangnan Li
Publikováno v:
FARMACIA. 67:1041-1047
Abstract 5511: Immune masking strategies to extend the pharmacokinetics of allogeneic cell therapies
Publikováno v:
Cancer Research. 82:5511-5511
The dramatic success of CAR T cell therapies in the treatment of certain B cell malignancies has led to a wave of novel cell therapies for cancer. All approved engineered cell therapies are derived from autologous T cells. This has posed barriers for